USA receiving check
Identify the US receiving importer and exact product.
For medicine sourcing from India to the USA, begin with the exact product, strength and pack. Commercial imports and personal-use enquiries follow different requirements. Share the intended recipient and quantity so product information, available documents and the applicable FDA guidance can be reviewed before shipment planning.
Identify the US receiving importer and exact product.
Branded and generic medicines across relevant therapeutic categories, with product information and quotation support.
Invoice, packing information, manufacturer details, COA or COO support where applicable and available.
Start with your buyer type and the exact medicine. The relevant receiving route must be checked for each request.
FDA says personal importation of foreign medicines not approved in the US is generally unlawful. Limited enforcement discretion is not permission or a right to import. Review the exact case with your clinician and FDA.
Identify the US receiving importer and exact product. Confirm the applicable FDA requirements for approval, establishment registration, drug listing, labelling and manufacturing before planning commercial supply.
Include the product, strength, dosage form, pack size, quantity, destination and intended use. Available product documents and handling requirements can then be discussed.
Official destination guidance
US commercial buyers should confirm the exact product approval pathway, manufacturer establishment registration, drug listing and US labelling before planning an import. An Indian-market brand or a catalogue listing does not establish FDA approval. Share the intended US importer and product identifiers so the enquiry can be checked against the applicable requirements. Official import guidance.
Share the receiving organisation or buyer, postal destination and intended use. Confirm the applicable receiving route before requesting shipment coordination.
Buyers can also review support pages for bulk enquiries, hospital supply, cold-chain medicines, specialty sourcing and pharmaceutical documentation.
Buyers can browse category-specific enquiry pages for relevant products, strengths and pack sizes.
Individuals, importers, pharmacies, clinics, hospitals and procurement teams may send product enquiries for review. Acceptance of an enquiry does not confirm medicine availability, permission to supply or import eligibility.
FDA says personal importation of foreign medicines not approved in the US is generally unlawful. Limited enforcement discretion is not permission or a right to import. Review the exact case with your clinician and FDA.
Identify the US receiving importer and exact product. Confirm the applicable FDA requirements for approval, establishment registration, drug listing, labelling and manufacturing before planning commercial supply.
State the medicine or active ingredient, strength, dosage form, pack size, quantity, destination and buyer type. The team can then discuss product information and available documentation. Do not send medical histories or identity documents in an initial general enquiry.
No. Product availability and price do not establish permission to supply or import. The applicable receiving route and product requirements must be confirmed before shipment is arranged.
FDA reviews imported human drugs against US requirements, including approval or an applicable pathway, establishment registration, listing, labelling and manufacturing standards. A quotation is not FDA clearance, and personal-import guidance is not a commercial wholesale route.
No. FDA states that an NDC number or inclusion in the NDC Directory does not establish product approval. The receiving importer should check the exact product and applicable approval or other lawful pathway separately from its listing.